Our services
- Support with forming a UK entity and navigating the regulatory environment.
- Advice on choosing the right lab, office location and space for all business stages.
- Introduction to banking, accounting, legal and immigration advice.
- Access to London's business ecosystem, our business network and partners.
- Long-term support and advice on continuing to grow your business in London.
- Support in helping SMEs to find the right research partner in innovation development.
- Helping to facilitate international exposure for UK life science innovators.
- Specialist consulting on developing the right laboratory space for life sciences business.
Omer works closely with the London & Partners commercial delivery companies and various stakeholders in the London life sciences ecosystem. He provides support to international companies that are looking to expand their operations into London and the NHS.
Omer has commercial business development experience, working with multiple life sciences organisations across UK and Ireland. He also has a technical background through an MSc degree in Drug Discovery and Pharmaceutical Management from University College London (UCL).
Wael Muselmani, PhD
Senior Investment Manager, Life Sciences
Wael has more than 15 years of experience working in pharma companies, research institutions and not-for-profit organisations. He has held various posts in pharmaceutical sales and marketing, business development and academic research.
With a multidisciplinary scientific background in pharmacology, diagnostics and molecular biology, he supports international life sciences companies to set up in London and find the right collaboration and partnership opportunities.
Ivana Poparic, PhD
Head of Life Sciences, Cluster Development
Ivana leads MedCity’s cluster development team with a focus on life sciences infrastructure and real estate development, as well as international relationships to attract more inward investment and research collaborations to London.
Ivana has extensive scientific and commercial expertise across the innovation pathway for drugs, devices and digital technologies. Her experience includes technology transfer, clinical research, investment and business development.